Bristol-Myers Squibb Company (BIT:1BMY)

Italy flag Italy · Delayed Price · Currency is EUR
51.51
+0.47 (0.92%)
Last updated: Feb 11, 2026, 2:36 PM CET
Market Cap102.82B -12.1%
Revenue (ttm)41.05B -0.2%
Net Income6.01B
EPS2.95
Shares Outn/a
PE Ratio17.11
Forward PE9.55
Dividend1.63 (3.16%)
Ex-Dividend DateOct 2, 2025
Volume637
Average Volume109
Open51.38
Previous Close51.04
Day's Range51.30 - 51.51
52-Week Range36.68 - 56.61
Betan/a
RSI68.29
Earnings DateFeb 5, 2026

About BIT:1BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat ... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Borsa Italiana
Ticker Symbol 1BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements